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Notable research in drug delivery started in 1950’s with the advent of polyclonal antitumor antibodies developed for targeting. 
Bangham et. Al. discovered liposomes in early 1960’s. In this review article we are discussing about the liposome, methods of the 
liposome preparation advantages and their different application of the liposome. Liposomes are artificially prepared vesicles made of 
lipid bilayer. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Liposome is used for the 
targeted drug delivery system and increase the bioavailability and half life of the any drugs. Liposomes are surfactants, 
sphingolipids, glycol-lipids, long chain fatty acids and even membrane proteins and drug molecules or it is also called vesicular 
system. Liposomes have been extensively investigated for drug delivery, drug targeting, controlled release and increased solubility. 
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INTRODUCTION 
Liposomes are described by British haematologist Dr. Alec D 
Bangham FRS in 1961 from the Babraham Institute at 
Cambridge. The name liposome is derived from Greek words 
'Lipos' means fat and 'Soma' means body. Liposome means 
lipid body, spherical microscopic vesicle are composed of one 
or more concentric lipid bilayer separated by water and 
aqueous buffer  compartment with a diameter ranging from 
25nm- 1000nm.[1] Liposome are defined As “Liposome are the 
simple microscopic vesicles wherein an aqueous volume is 
entirely enclosed by a membrane composed of lipid molecule.” 
Various amphipathic molecules are used to form liposome. The 
drug molecules can either be encapsulated in aqueous space or 
intercalated into the lipid bilayer.[2] 
 
Fig 1 Liposome formed by phospholipids in aqueous solution 




There are several advantages of the liposome- 
 Provides selective passive targeting to tumour tissue 
(liposomal doxorubicin). 
 Liposome are biocompatible, completely biodegradable, 
non-toxic and non immunogenic. 
 Suitable for the delivery of hydrophobic, amphipathic and 
hydrophilic drugs. 
 Site avoidance effect. 
 Protect the encapsulated drug from external environment.  
 Increased efficacy and therapeutic index. 
 Increased stability via encapsulation. 
 Reduce exposure of sensitive tissue to toxic drug. 
 Improve protein stabilization. 
 Provide sustained release.  





 Production cost is high. 
 Leakage and fusion of encapsulated drug /molecules. 
 Sometimes phospholipids undergo oxidation and 
hydrolysis like reaction. 
 Short half-life. 
 Low solubility 
 Less stability 
 Quick uptake by cells of R.E.S 
 Allergic reactions may occur to liposomal constituents 
 Problem to target various tissues due to their large size 




Liposome may be produced by a wide variety of methods. 
Their nomenclature also depends upon the method of 
preparation, Structural parameters or special function assigned 
 
LIPID FILM HYDRATION BY HAND SHACKING:- 
[7] 
Liposome was prepared by physical dispersion technique using 
different ratio of lipid. In this method the lipids was dissolved 
in chloroform. This solution of lipid in chloroform is spread 
over flat bottom conical flask. The solution was then 
evaporated at room temperature with no disturbing the solution. 
The hydration of lipid film appearance was carried out with 
phosphate buffer (pH 7.4) was inclined to one side and aqueous 
medium containing drug to be entrapped and  introduced into 
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the side of flask and flask was slowly return to upright 
orientation. The fluid was allowed to run quietly over lipid 
layer and flask was allowed to stand for 2 hr at 37 0C for 
complete swelling, after swelling, vesicles are harvested by 
swirl the contents of flask to yield milky white suspension. 
Then formulations were subjected to centrifugation. Different 
batches of liposome were prepared in order to select an 
optimum formula. All batches of liposome were prepared as 
per the method described above and composition of lipids for 





The Sonication is most extensively method used for the 
preparation of SUVs. Here, MLVs are sonicated either with 
bath type sonicator or probe type sonicator under a passive 
atmosphere. The main disadvantage of this method is very low 
internal volume, low encapsulation efficacy, degradation of 
phospholipids and elimination of large molecules, metal 
pollution from probes tip, and presence of MLV along with 
SUV. There are two sonication techniques:- 
 
a) Probe sonication: These sonicator is directly engrossed into 
the liposome dispersion. In this method energy input into lipid 
dispersion is very high. The coupling of energy at tip results in 
local hotness, therefore, the vessels must be engrossed into 
water or ice bath. Throughout the sonication up to 1 h, more 
than 5% of the lipids can be deesterified.  With the probe 
sonicator titanium determination slough off and pollute the 
solution. 
 
b) Bath sonication: The cylinder containing liposomes is 
placed into a bath sonicator at controlled temperature it is 
usually easier method, in contrast to sonication by dispersion 
directly using the tip. The material is being sonicated and can 
be protected in a sterile vessel, dissimilar the probes unit, or 
under an inert atmosphere. 
 
 
                                                    
Based on structure parameters                                                  Based on method of liposome preparation 
SUV- Small Unilamellar vesicles (20-100nm)     REV- Single or Oligo lamellar vesicle by reverse- phase evaporation method       
MUV- Medium sized Unilamellar vesicles    MLV-REV- Multilamellar vesicles made by  reverse- phase evaporation method 
LUV- large Unilamellar vesicles >100                                                                 SPLV- Stable plurilamellar vesicles 
MLV- Multilamellar  large vesicles->0.5mm                                                       FATMLV- Frozen and thawed  MLV 
OLV- Oligolamellar vesicles-0.1-1mm                                                                 VET- Vesicles prepared by extrusion technique 
UV- Unilamellar vesicles (All size ranges) DRV- Dehydration –rehydration method   
GUV- Giant Unilamellar vesicles->1mm  
MV-Multivesicular  vesicles->1mm  
                                                         Method of liposome preparation 
 
Mechanical dispersion method                Solvent dispersion method                           Detergent removal methods  
 Lipid film hydration by hand shacking,     (1) Ethanol injection                 (1) Detergent ( chlorate, Aglycoside 
 Non-hand shacking or freeze drying          (2) Ether injection                         Triton X-100) Removal from mixed          
 Micro-emulsification                                  (3) Double emulsion vesicles                                  micelles by    
 Sonication                                                  (4) Reverse phase evaporation vesicles        - Dialysis    
 French- pressure cell                                 (5) Stable plurilamellar vesicles                    - Column chromatography                                   
 Membrane extrusion                                                                                                        - Dilution  
 Dried reconstituted vesicles                                                                                             - Reconstituted Sendai virus   





Micro-fluidizer is used for the preparation of small vesicles 
from concentrated lipid suspension. The lipids can be 
introduced into the fluidizer as a suspension of large MLVs. 
The equipment pumps fluid at very high pressure through 5 
mm screen. Then it is forced with long micro channels, which 
Journal of Applied Pharmaceutical Research ISSN No. 2348 – 0335 www.japtronline.com 
 
 
July – September 2015 Volume 3                                       Issue 3  3 
 
dried two streams of fluids, collide together at right angles at 
very high velocity. The collected fluid can be recycled by using 
pump and in interaction chamber until vesicles of spherical 





French pressure cell involves the extrusion of MLV though a 
small orifice in important feature of the French pressure vesicle 
method is that the protein do not seem to the significantly 
during the procedure as they are in sonication. The method 
involves gentle handling of unstable methods. The method has 
several advantages over sonication method. The resulting 
liposome are rather larger the sonicated SUVs. The drawbacks 
of the method are that the high temperature is difficult to 
achieve and the working volumes are comparatively small 





The lipid mixture is added to round bottom flask and the 
solvent is removed under pressure by a rotary evaporation. The 
system is purge with nitrogen and lipids are re-dissolved in the 
organic phase, vesicles will form. Diethyl ether and isopropyl 
ether are the usual solvent of choice after the lipids are re-
dissolved the emulsion are obtained and then the solvent is 
evaporated from an emulsion by evaporation to a semisolid gel 
under reduced pressure and non encapsulated material is then 
removed. The resulting liposome are called reverse phase 
evaporation vesicle (REV). This method is the preparation of 





Ether injection, a solution of lipids is dissolved in ether or 
diethyl ether or methanol mixture which is slowly injected in 
aqueous solution of the material to be capsulation.The 
successive removal of the organic solvent under reduced 
pressure leads to the formation of liposome. The main 
disadvantage of the method is heterogeneous population and 
the exposure of compound to be encapsulating to organic 





 The ethanol injection method is ethanolic lipid solution is 
rapidly injected to a vast excess of preheated distilled water or 
TRIS-HCl buffer. The incorporation of the drug in liposomal 
vesicle depends on its hydrophilic/hydrophobic character. 
Nimesulide is lipid soluble component incorporates better in 
liposomes than 5-fluorouracil which migrates to external 
aqueous phase. The main advantage of ethanol injection 
method is including of non harmful solvent as ethanol method. 
The possibility formation of azeotrope with water reduces its 
applicability. 
 
MECHANISM OF LIPOSOME FORMATION 
In the order to understand why liposome is formed when 
phospholipids are hydrated, it requires basic understanding 
physiochemical phospholipids. Phospholipid is amphipathic 
molecules as hydrophobic tail and hydrophilic polar head. The 
hydrophobic tail is composed two fatty acid chain containing 
10-24 carbon atoms and 0-6 double bonds in each chain. The 
polar end molecules are mainly phosphoric acid bound to a 
water- soluble molecule. The hydrophilic and hydrophobic 
domain/segment molecular geometry of amphiphilic lipid 
orient and self organize in ordered supramolecular structure 
confronted with solvent. 




These are derived from the phosphatidic acid. The back bone of 
the molecules is glycerol moieties.  Glycerol containing 
phospholipids are the most common used component of 
liposome formulation and represent the greater than 50% of 
weight of lipid in biological   membranes. At C3 OH group is 
esterified to phosphoric acid. 
Example of phospholipids ar 
 Phosphatidyl choline (Lecithin) 
 Phosphatidyl ethanolamine (Cephalin) 
 Phosphatidyl serine (PS) 
 Phosphatidyl inositol (PI) 
 Phosphatidyl glycerol (PG) 
For stable liposomes, saturated fatty acids are used. 
Unsaturated fatty acids are not used generally.  




It is Backbone of sphingosine or a related base. These are the 
important constituents of plant and animal cells. This contains 
3 characteristic building blocks. 
 A mole of Fatty acids 
 A mole of sphingosine  
 A head group can vary from simple alcohol such as 
choline to very complex carbohydrates. 
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Most common Sphingolipids- Sphingomyelin.  
 Glycosphingo lipids. 
 Gangliosides- Found on grey matter, used as miner 
component for liposome production.  
This molecule contain complex saccharides with the residues 
Sialic acid and their polar     head group and thus have one or 
more negative charge at neutral pH.The liposome added          
in to provide a surface charged layer group. 
Sterols- 
[4][3] 
Cholesterol & derivative are often included in liposomes for- 
 declining the fluidity or microviscosity of the bilayer 
 falling the permeability of the membrane to water soluble 
molecules 
 stabilize the membrane in the presence of biological fluids 
such as plasma (This effect used in the formulation of  i.v. 
liposomes ) 
Liposome without cholesterol interacts with plasma proteins 
viz. albumin, transferrine, and macroglobuline. These proteins 
tend to extract bulk phospholipids from liposome, thus 





Example: For saturated phospholipids are- 
 Dipalmitoyl  Phosphatidyl choline (DPPC) 
 Disteroyl Phosphatidyl choline (DSPC) 
 Dipalmitoyl Phosphatidyl ethanolamine (DPPE)   
 Dipalmitoyl Phosphatidyl serine (DPPS) 
 Dipalmitoyl phosphatidic acid (DPPA) 
 Dipalmitoyl phosphatidyl glycerol (DPPG) 
Example: For unsaturated phospholipids are-  
 Dioleoyl Phosphatidyl choline (DOPC) 





Synthetic phospholipids with diactylenic group in hydrocarbon 
chain polymerizes when exposed to U.V. leading to the 
formation of polymerized liposome having significantly higher 
permeability barriers to entrapped aqueous drugs. Ex. For other 
polymerisable lipids are- lipids containing conjugated dienes, 
Methacrylate etc. Also several polymerisable surfactants are 
also synthesized. 
Polymer bearing lipids-[3]  
Stability of repulsive interaction with macromolecules is 
governed mostly by repulsive electrostatic forces. This 
repulsion can be induced with coating liposome surfaces by 
charge polymers.Non- ionic and water compatible polymer like 
polyethylene oxide; Polyvinyl alcohol and polyoxazolidine 
confer higher solubility. But adsorption of such copolymer 
containing hydrophilic segments with hydrophobic part lead to 
the liposome leakage, so best results can be achieved by 
covalently attaching polymers to phospholipids. Ex. Diacyl 
phosphatidyl ethanolamine with PEG polymer linked via a 
carbon at or succinate bond. 
 
Cationic lipids- [3] 
E.g.: Dioctadecyl dimethyl ammonium bromide or chloride 
(DODAB/C) 
DOTAP- Dioleoyl propyl trimethyl ammonium chloride- This 
is analogue of DOTAP and various other including various 
analogues of DOTMA and cationic derivatives of cholesterol. 
        
Other substances-                                                                                                                                                                          
 Variety of other lipid of surfactants is used  
 Many single chain surfactants can form liposome mixing 
with cholesterol 
 Non ionic lipid.  
  Variety of polyglycerol and polyethoxylated mono and 
dialkyl amphiphiles used many in cosmetics preparation.  
 Single and double chain lipids having fluoro carbon chain 
can form very stable liposome. 
 Sterylamine and Dicetyl phosphate. 
 Incorporated into liposomes so as to impart either a 
negative or positive surface charge to these structures 
 




 Liposomes are the manufactured in majority using various 
procedures in which the water soluble (hydrophilic) materials 
are entrapped by using aqueous solution of these material as 
hydrating fluid or by the addition of drug/drug solution at some 
stage during manufacturing of the liposome. The lipid soluble 
(lipophilic) materials are solubilized in the organic solution the 
constitutive lipid and then evaporated dry drug containing lipid 
film followed by its hydration. These methods involve the 
loading the entrapped agents before or during manufacturing 
procedure (passive loading). Certain type of compounds by can 
be introduced the liposomes after the formation of intact 
vesicles.
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Fig: - general method of liposome preparation 
EVALUATION OF LIPOSOMES 
[11]
 
The liposomal formulation and processing for specified 
purpose are characterized to ensure their predictable in vitro 
and in vivo performance. The characterization parameters for 
purpose of evaluation could be classified into three stapes 
physical, chemical and biological parameters. Physical 
characterization evaluate parameter includes size, shape, 
surface, and drug release profile. Chemical characterization 
includes studies in establish the purity and potency of various 
lipophillic constituents. Biological characterizations parameters 
are helpful in establish the safety and suitability of formulation 
for therapeutic application. Some of parameters are:- 
Vesicle shape and lamellarity 
The Vesicle shape assessed using electron Microscopic 
Techniques. Lamellarity of vesicles is determined by Freeze 
Fracture Electron Microscopy and P31 Nuclear Magnetic 
Resonance Analysis. 
Vesicle size and size distribution 
The liposome size distribution was determined by the photon 
correlation spectroscopy  
Microscopic Techniques Optical Microscopy
[11]
 
The microscopic method includes use the Bright Field, phase-
Contrast Microscope and Fluorescent Microscope and is useful 
in evaluating vesicle size of large vesicles. 
 CRYO-Transmission Electron Microscopy Techniques 
(CRYO-TEM) 
 This technique has been used to elucidate the surface 
morphology and size of vesicles.  
Diffraction and Scattering Techniques:-
[11]
 
Laser Light Scattering Photon correlation spectroscopy 
(PCS):- The analysis of time dependence of intensity 
fluctuation in scattered laser light due to Brownian motion of 
particles in solution or suspension since small particles diffuse 
more than large particles, the rate of fluctuation scattered light 
intensity varies accordingly.  The translational diffusion 
coefficient (D) can be measured and can be used to determine 
the mean hydrodynamic radius (RHSS) of particles using the 
Stoke-Einstein equation using this technique one can measure 
particles in range of about 3nm. 
Hydrodynamic Techniques:- 
This technique includes gel Permeation and Ultracentrifuge. 
Exclusion chromatography on large pure gels was introduced to 
separate SUVs from radial MLVs.The large vesicles of 1- 
3µmdiameter.usually fail to enter the gel and is retained on top 
of column. A thin layer chromatography system using agarose 
beads has been introduced as a convent, fast technique for 
obtaining a rough estimation of size distribution of liposome 
preparation. However, it was not reported if this procedure was 










Liposomal          
suspension 
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sensitive to a physical blockage of pores of the agars gel as is 
the more conventional column chromatography. 
Zeta potential determination- 
[16]
 
The zeta potential was evaluated by the determination of 
electro mobility of the 90c angle. The measurement was 
performed in triplicate using the 3000 HS zeta-seizer 
equipment. The sample was diluted with suitable diluents for 
the potential determination.     
 
APPLICATIONS OF LIPOSOMES 
Systemic Liposomal Drugs 
[18]
 
After systemic (usually intravenous) administration, liposomes 
are typically recognized as foreign particles and consequently 
endocytose by the mononuclear phagocyte system cells mostly 
fixed Kuppfer cells, in the liver and spleen. Liposome can serve 
as an excellent drug-delivery vehicle cells. sterically stabilized 
liposome is not avidly taken up by mononuclear phagocyte 
cells, have different bio distributions properties and have 
shown enhanced accumulation in sites of trauma, tumour, 
infection and inflammation. This accumulation is simply due to 
their prolonged circulation and small size; enabling them to 
extravasate 
Topical Liposomal Drugs [19] 
The skin treatment applications of liposomes are based on the 
similarity between the lipid vesicles bilayer structure and 
natural membrane are include the ability of lipid vesicle with 
specific lipid composition, to alter cell membrane fluidity and 
to fuse in the dermatological field, liposomes were initially 




 The properties of liposomes utilized also in the delivery of 
ingredients in cosmetics. Liposomes offer advantages because 
lipids are hydrated and reduce the dryness of the skin which is 
a primary cause for ageing. Also, liposomes supply replenishes 
lipids and importantly linolenic acid to the skin. The first 
liposomal cosmetic product to appear on  market was the anti-
ageing cream Capture launched by Christian Dior in 
1986.Liposomes have been also used in the treatment of hair 
loss minoxidil a vasodilator in the active ingredient in products 
like “Regaine” that claim to prevent or slow hair loss. The skin 
care preparations with empty or moisture loaded liposome 
reduce the transdermal water loss and suitable for the treatment 
of dry skin. They also enhance the supply of lipids and water to 





The majority of microencapsulation techniques at present used 
in the food industry are based on biopolymer matrices 
composed of sugar, starch, gum, protein, synthetic, dextrin and 
alginates. Nevertheless, liposomes have recently begun to gain 
in importance in food products. 
Liposomes in anticancer therapy 
[25] [26] [27] 
The different liposome formulations of various anticancer 
agents were shown to be less toxic than the free drug. 
Anthracyclines are drugs stop the growth of dividing cells by 
intercalating the DNA and therefore kill predominantly quickly 
dividing cells. These cells in tumours, but also gastrointestinal 
mucosa, hair, and blood cells and therefore this class of drugs 
are very toxic. The most used and studied is Adriamycin. In 
addition to the above mentioned acute toxicities its dosage is 
limited by cumulative cardio toxicity. Different formulations 
were tried. In most cases the toxicity was reduced about 50% 
includes both, short term and chronic toxicities because 
liposome encapsulation reduces the distribution of drug 
molecules towards tissues. For the same reason, on the other 
hand, the efficacy was in many cases compromised due to 
reduced bioavailability of the drug, especially if the tumour 
was not phagocytic or located organs of mononuclear 
phagocytic system. In cases, such as systemic lymphoma, the 
effect of liposome encapsulation show enhanced efficacy the 
sustained release effect. Ex longer presence of therapeutic 
concentrations in the circulation while in several other cases 
the sequestration of the drug tissues of mononuclear phagocytic 
system actually reduced its efficacy and applications in man 
show in general reduced toxicity, better tolerability of 
administration with not too encouraging efficacy. The different 
formulations are different phases of clinical studies and show 
mixed results. 
Liposomes in medicine & pharmacology 
[28] [29] [30]
 
The liposomes in medicine and pharmacology can be divided 
into diagnostic and therapeutic application of liposome 
containing various marker drugs and their use as a tool, model, 
or reagent in the basic studies of cell interaction, recognition 
process, and mode of action of certain substance. 
Unfortunately, drugs are the very narrow therapeutic window, 
meaning that the therapeutic concentration is not lower than the 
toxic one. In cases, the toxicity can be reduced the efficacy can 
be enhanced the used of suitable drug carrier which alters the 
temporal and spatial delivery of the drug, i.e. it biodistribution 
and pharmacokinetics is clear from many pre-clinical and 
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clinical studies that drug, for the instance antitumor drug, 
parceled in liposome demonstration reduced toxicities, while 
retentive enhanced efficacy. 
Advances in liposome design are the leading in new 
applications for the delivery of new biotechnology products, 
example for the antisense oligonucleotide, cloned gene, and 
recombinant protein. A vast literature define the viability of 
formulating wide range conservative drugs in liposome, 
frequently resultant in improved therapeutic activity and 
reduced toxicity compared with free drug. Changed 
pharmacokinetics for liposomal drugs can lead to improved 
drug bioavailability to the particular target cells and live in the 
circulation, or more prominently, to extravascular disease sites, 
example for tumors recent improvement consist of liposomal 
formulation of all-trans-retinoic acid. 
 
CONCLUSION 
The present study demonstrated that Liposomes are one of the 
unique drug delivery system, They can be use in controlling 
and targeting drug delivery. These are also used in the cosmetic 
and hair Technologies, diagnostic purpose and good carrier in 
gene delivery. Liposome carriers, well known for their 
potential application. Liposome is giving a good and 
encouraging result in the anticancer therapy and human 
therapy. Liposomes are acceptable and superior carriers and 
have ability to encapsulate hydrophilic as well as lipophillic 
drugs and protect them from degradation. As a novel carrier 
system liposomes provide controlled and sustained release. 
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